-
Snell & Wilmer Product Liability Group
Experienced trial attorneys. Trusted advisors. Counseling companies across the country and throughout their products' lifecycles.
Click the map below to expand.
-
Follow us on Twitter
-
Recent Posts
Topics
- asbestos
- automotive
- autonomous vehicles
- biosimilar
- consumer products
- CPSC
- cybersecurity
- damages
- FDA
- food
- guidance
- Internet of Things
- jury
- litigation
- medical
- medical devices
- mobile
- NHTSA
- pharmaceutical
- privacy
- products
- recalls
- Trials
- Trucking/transportation
- Uncategorized
- unmanned aircraft systems/"drones"
- verdicts
FDA Approves Second Biosimilar – Inflectra™ – The First Monoclonal Antibody Biosimilar
The U.S. Food and Drug Administration announced on April 5 its second ever approval of a biosimilar – Inflectra (infliximab-dyyb) – for multiple indications. Inflectra was developed by Celltrion Inc. and licensed to Pfizer Inc., for treatment of rheumatoid arthritis, … Continue reading
Posted in biosimilar, FDA, pharmaceutical
Share this Article:
